These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15645018)

  • 1. Focus on small molecule inhibitors for treatment of inflammatory and autoimmune diseases.
    Borchardt JK
    Drug News Perspect; 2004 Nov; 17(9):607-14. PubMed ID: 15645018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug evaluation: apilimod, an oral IL-12/IL-23 inhibitor for the treatment of autoimmune diseases and common variable immunodeficiency.
    Billich A
    IDrugs; 2007 Jan; 10(1):53-9. PubMed ID: 17187316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha inhibitors offer hope to RA patients.
    Wimett L
    Nurse Pract; 2003 Oct; 28(10):40-8. PubMed ID: 14560130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(4):262a. PubMed ID: 29176292
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Chemical Society--229th National Meeting. Oral and poster presentations.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):285-7. PubMed ID: 15800797
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging role of IL-35 in inflammatory autoimmune diseases.
    Su LC; Liu XY; Huang AF; Xu WD
    Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab in the treatment of immune-mediated diseases.
    Lapadula G; Marchesoni A; Armuzzi A; Blandizzi C; Caporali R; Chimenti S; Cimaz R; Cimino L; Gionchetti P; Girolomoni G; Lionetti P; Marcellusi A; Mennini FS; Salvarani C
    Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):33-48. PubMed ID: 24774505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-alpha therapies: the next generation.
    Palladino MA; Bahjat FR; Theodorakis EA; Moldawer LL
    Nat Rev Drug Discov; 2003 Sep; 2(9):736-46. PubMed ID: 12951580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Niikura M; Wada Y; Okada AA
    Arthritis Res Ther; 2008; 10(5):R122. PubMed ID: 18847496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments.
    Veys EM; Mielants H; Verbruggen G; De Keyser F
    Baillieres Clin Rheumatol; 1992 Jun; 6(2):455-84. PubMed ID: 1525848
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tumor necrosis factor a inhibitors in treatment of Crohn's disease].
    Vermel' AE
    Klin Med (Mosk); 2005; 83(11):13-7. PubMed ID: 16404932
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammation Research Association--14th International Conference.
    Harrop S
    IDrugs; 2006 Dec; 9(12):846-8. PubMed ID: 17139571
    [No Abstract]   [Full Text] [Related]  

  • 14. Onercept. Serono.
    Nikas SN; Drosos AA
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1369-76. PubMed ID: 14758777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.
    Armuzzi A; Lionetti P; Blandizzi C; Caporali R; Chimenti S; Cimino L; Gionchetti P; Girolomoni G; Lapadula G; Marchesoni A; Marcellusi A; Mennini FS; Salvarani C; Cimaz R
    Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):11-32. PubMed ID: 24774504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator.
    van Eden W
    Curr Opin Investig Drugs; 2008 May; 9(5):523-33. PubMed ID: 18465663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies in chronic autoimmune inflammatory diseases].
    Semerano L; Boissier MC
    Med Sci (Paris); 2009 Dec; 25(12):1108-12. PubMed ID: 20035687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of p38 mitogen-activated protein kinase: potential as anti-inflammatory agents in asthma?
    Newton R; Holden N
    BioDrugs; 2003; 17(2):113-29. PubMed ID: 12641490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis: TNF-alpha inhibitors and beyond.
    Kincaid L
    Drug Discov Today; 2005 Jul; 10(13):884-6. PubMed ID: 15993806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.